{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T12:11:04Z","timestamp":1753877464490,"version":"3.41.2"},"reference-count":12,"publisher":"Oxford University Press (OUP)","issue":"12","license":[{"start":{"date-parts":[[2020,10,29]],"date-time":"2020-10-29T00:00:00Z","timestamp":1603929600000},"content-version":"vor","delay-in-days":1,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,12,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Loiasis is a filarial disease endemic to areas of Central and West Africa. We present a case of Loa loa microfilaremia in a patient with HTLV-1-related adult T-cell lymphoma. This case may suggest the possible role of cellular immunity in controlling microfilaria burden.<\/jats:p>","DOI":"10.1093\/ofid\/ofaa526","type":"journal-article","created":{"date-parts":[[2020,10,29]],"date-time":"2020-10-29T01:20:51Z","timestamp":1603934451000},"source":"Crossref","is-referenced-by-count":1,"title":["Slithering Through the Bone Marrow: Loiasis in a Patient With Human T-Cell Leukemia Virus-1-Associated Adult T-Cell Lymphoma"],"prefix":"10.1093","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6894-2262","authenticated-orcid":false,"given":"Carl","family":"Boodman","sequence":"first","affiliation":[{"name":"Section of Infectious Diseases, Department of Internal Medicine, Max Rady College of Medicine, University of Manitoba, Winnipeg, Manitoba, Canada"},{"name":"Department of Medical Microbiology and Infectious Diseases, Max Rady College of Medicine, University of Manitoba, Winnipeg, Manitoba, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Marko","sequence":"additional","affiliation":[{"name":"Department of Pathology, Max Rady College of Medicine, University of Manitoba, Winnipeg, Manitoba, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoav","family":"Keynan","sequence":"additional","affiliation":[{"name":"Section of Infectious Diseases, Department of Internal Medicine, Max Rady College of Medicine, University of Manitoba, Winnipeg, Manitoba, Canada"},{"name":"Department of Medical Microbiology and Infectious Diseases, Max Rady College of Medicine, University of Manitoba, Winnipeg, Manitoba, Canada"},{"name":"Department of Community Health Sciences, Max Rady College of Medicine, University of Manitoba, Winnipeg, Manitoba, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2020,10,28]]},"reference":[{"key":"2020122901401426400_CIT0001","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1128\/AAC.01413-10","article-title":"Integrase inhibitors effective against human T-cell leukemia virus type 1","volume":"55","author":"Seegulam","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"2020122901401426400_CIT0002","doi-asserted-by":"crossref","first-page":"2044","DOI":"10.1056\/NEJMoa1705026","article-title":"A test-and-not-treat strategy for onchocerciasis in Loa loa-endemic areas","volume":"377","author":"Kamgno","year":"2017","journal-title":"N Engl J Med"},{"key":"2020122901401426400_CIT0003","first-page":"S2","article-title":"Report of a Scientific Working Group on serious adverse events following Mectizan(R) treatment of onchocerciasis in Loa loa endemic areas","volume":"2","year":"2003","journal-title":"Filaria J"},{"key":"2020122901401426400_CIT0004","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1186\/s13071-017-2103-y","article-title":"Loa loa vectors Chrysops spp.: perspectives on research, distribution, bionomics, and implications for elimination of lymphatic filariasis and onchocerciasis","volume":"10","author":"Kelly-Hope","year":"2017","journal-title":"Parasit Vectors"},{"key":"2020122901401426400_CIT0005","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/S0140-6736(96)11094-1","article-title":"Serious reactions after mass treatment of onchocerciasis with ivermectin in an area endemic for Loa loa infection","volume":"350","author":"Gardon","year":"1997","journal-title":"Lancet"},{"key":"2020122901401426400_CIT0006","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/S1473-3099(16)30405-4","article-title":"Excess mortality associated with loiasis: a retrospective population-based cohort study","volume":"17","author":"Chesnais","year":"2017","journal-title":"Lancet Infect Dis"},{"key":"2020122901401426400_CIT0007","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1046\/j.1365-3156.1999.00442.x","article-title":"Genetic epidemiology of host predisposition microfilaraemia in human loiasis","volume":"4","author":"Garcia","year":"1999","journal-title":"Trop Med Int Health"},{"key":"2020122901401426400_CIT0008","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1093\/cid\/cix877","article-title":"Familial aggregation and heritability of Loa loa microfilaremia","volume":"66","author":"Eyebe","year":"2017","journal-title":"Clin Infect Dis"},{"key":"2020122901401426400_CIT0009","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1046\/j.1365-2249.1997.d01-1010.x","article-title":"T helper responsiveness in human Loa loa infection; defective specific proliferation and cytokine production by CD4+ T cells from microfilaraemic subjects compared with amicrofilaraemics","volume":"108","author":"Baize","year":"1997","journal-title":"Clin Exp Immunol"},{"key":"2020122901401426400_CIT0010","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1046\/j.1365-3024.2001.00407.x","article-title":"HTLV-1 decreases Th2 type of immune response in patients with strongyloidiasis","volume":"23","author":"Porto","year":"2001","journal-title":"Parasite Immunol"},{"key":"2020122901401426400_CIT0011","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1086\/423941","article-title":"Provirus load in breast milk and risk of mother-to-child transmission of human T lymphotropic virus type I","volume":"190","author":"Li","year":"2004","journal-title":"J Infect Dis"},{"key":"2020122901401426400_CIT0012","doi-asserted-by":"crossref","first-page":"125","DOI":"10.11604\/pamj.2018.30.125.14802","article-title":"Prevalence and risk factors of HTLV-1\/2 and other blood borne infectious diseases among blood donors in Yaounde Central Hospital, Cameroon","volume":"30","author":"Kengne","year":"2018","journal-title":"Pan Afr Med J"}],"container-title":["Open Forum Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ofid\/advance-article-pdf\/doi\/10.1093\/ofid\/ofaa526\/34051191\/ofaa526.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/ofid\/article-pdf\/7\/12\/ofaa526\/35224855\/ofaa526.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/ofid\/article-pdf\/7\/12\/ofaa526\/35224855\/ofaa526.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,12,29]],"date-time":"2020-12-29T06:40:42Z","timestamp":1609224042000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ofid\/article\/doi\/10.1093\/ofid\/ofaa526\/5942620"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,28]]},"references-count":12,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2020,12,1]]}},"URL":"https:\/\/doi.org\/10.1093\/ofid\/ofaa526","relation":{},"ISSN":["2328-8957"],"issn-type":[{"type":"electronic","value":"2328-8957"}],"subject":[],"published-other":{"date-parts":[[2020,12]]},"published":{"date-parts":[[2020,10,28]]},"article-number":"ofaa526"}}